Carmignac Gestion Corbus Pharmaceuticals Holdings, Inc. Transaction History

Carmignac Gestion

  • $5.82 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 13, 2020
SELL
$1.5 - $9.38 $5.66 Million - $35.4 Million
-3,773,440 Closed
0 $0
Q2 2020

Aug 13, 2020
BUY
$4.79 - $8.39 $14.6 Million - $25.5 Million
3,041,655 Added 415.65%
3,773,440 $31.7 Million
Q1 2020

May 14, 2020
BUY
$3.44 - $7.21 $2.52 Million - $5.28 Million
731,785 New
731,785 $3.84 Million

Others Institutions Holding CRBP

# of Institutions
4
Shares Held
38.7K
Call Options Held
0
Put Options Held
0
View Full List

About Corbus Pharmaceuticals Holdings, Inc.

CRBP Quotes by TradingView
  • Ticker CRBP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 125,268,000
  • Market Cap $1.64B
  • Description
  • Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, focuses on the development of immune modulators for immuno-oncology and fibrosis diseases. It develops lenabasum, an oral molecule that selectively activates cannabinoid receptor type 2 (CB2), which is in Phase II clinical trial to treat systemic lupus erythematosus; CRB-601, an...
More about CRBP
Track This Portfolio

Track Carmignac Gestion Portfolio

Follow Carmignac Gestion and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Carmignac Gestion, based on Form 13F filings with the SEC.

News

Stay updated on Carmignac Gestion with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email